Premium
Hypomethylating agent/venetoclax versus intensive chemotherapy in adults with relapsed or refractory acute myeloid leukaemia
Author(s) -
Jamy Omer,
Lin Karen,
Worth Sarah,
Bachiashvili Kimo,
Rangaraju Sravanti,
Vachhani Pankit,
Bhatia Ravi
Publication year - 2022
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.18229
Subject(s) - venetoclax , medicine , myeloid leukaemia , oncology , refractory (planetary science) , hypomethylating agent , chemotherapy , myeloid leukemia , myeloid , leukemia , biology , gene , biochemistry , gene expression , chronic lymphocytic leukemia , astrobiology , dna methylation
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom